Quantcast Probiodrug Closes Series B Financing Round Exceeding EUR 36 Million (US$54 Million) - Congoo
 
 
WORLD Log In
Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million)
Have an interest in this Story?
Sign Up for Real-Time email updates
Pharma Live  | November 03, 2009

Halle/Saale, November 2nd, 2009 -- Probiodrug AG (Probiodrug), a biotech company developing novel concepts and products for the treatment of neurodegenerative and inflammatory diseases with a particular focus on Alzheimer's disease, today announced the successful closing of a Series B financing roun...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Alexandr Migunov Alexandr Migunov
Head of the Project
Real Estate Industry
David Hood David Hood
Director
Marketing/Public Relations

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.